Original-Research: NFON AG (von NuWays AG): BUY
|
Original-Research: NFON AG - from NuWays AG
Classification of NuWays AG to NFON AG
Strong FY24p highlighted by superb FCF; chg. Topic: NFON released preliminary FY24 figures, showing a stronger than expected top- and bottom-line as well as an extraordinarily strong FCF. In detail: FY24 sales increased 6.1% yoy to € 87.3m (eNuW: € 86.1m; eCons: € 86.5m) driven by moderate seat growth (+1.4% to 665k) as well as premium solutions. Notably, non-recurring sales were up 95% yoy in Q4, indicating a strong effect from botarios project business and also a strong growth in Q4 as well as FY24 by the newly acquired subsidiary (consolidated since 09/24). According to CEO Heider, the company exceeded expectations and thus made a strong contribution to the FY result. Importantly, recurring revenues grew 5.1% yoy to € 81.1m (in line with eNuW), implying a recurring revenue ratio of 92.9%. FY24 adj. EBITDA improved disproportionately by 48% yoy to € 12.3m (eNuW: € 12.0m; eCons: € 11.3m), implying a margin of 14.1% (+3.9pp yoy). The improved profitability was mainly driven by an improved product mix (i.e. premium solutions), the imposed efficiency measures as well as the margin-accretive acquisition of botario (c. 30% EBITDA margin). Reported EBITDA was in line with our estimates at € 10.8m. The clear highlight of the release however was the FCF, which improved strongly from € 1.0m in FY23 to € 6.5m in FY24 and was substantially ahead of our estimate (eNuW: € 3.8m). The strong increase was mainly driven by the improved profitabilty as well as lower CapEx (eNuW). New guidance. For FY25e, management targets sales to grow by 8-10% (eNuW new: +10.4%) and an adj. EBITDA of € 13.5-15.5m (eNuW new: € 15.8m). In our view, both should be well achievable even at the upper end of the range. This should be driven by (1) the continuous efficiency gains, (2) a further improvin product mix as well as (3) the introduction of new solutions like NFON Intelligent Assistent or voice mail transcription. Despite the recent share price jump (+45% YTD), this is still not adequately reflected in the share price, in our view, given a valuation of 7.3x EV/EBITDA FY25e (5.5x FY26e). We hence reiterate BUY with an increased € 12.30 PT (old: € 11.70) based on DCF. The stock remains part of our NuWays Alpha List. You can download the research here: http://www.more-ir.de/d/31869.pdf For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
||||||||||||||||||||
2093177 28.02.2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 57,12 | 67,60 | 75,89 | 80,79 | 82,34 | 87,30 | 95,20 | |
| EBITDA1,2 | -6,98 | 2,32 | -2,03 | -5,27 | 6,80 | 10,80 | 13,90 | |
| EBITDA-Margin3 | -12,22 | 3,43 | -2,68 | -6,52 | 8,26 | 12,37 | 14,60 | |
| EBIT1,4 | -9,99 | -1,83 | -8,97 | -12,03 | -0,52 | 2,85 | 7,00 | |
| EBIT-Margin5 | -17,49 | -2,71 | -11,82 | -14,89 | -0,63 | 3,27 | 7,35 | |
| Net Profit (Loss)1 | -10,92 | -2,24 | -8,91 | -15,58 | -0,80 | 1,80 | 4,60 | |
| Net-Margin6 | -19,12 | -3,31 | -11,74 | -19,29 | -0,97 | 2,06 | 4,83 | |
| Cashflow1,7 | -7,19 | 1,15 | -1,76 | -3,87 | 6,84 | 7,30 | 11,00 | |
| Earnings per share8 | -0,77 | -0,15 | -0,54 | -0,94 | -0,05 | 0,11 | 0,28 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: KPMG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| NFON | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0N4N5 | DE000A0N4N52 | AG | 111,79 Mio € | 11.05.2018 | Kaufen | 8FWH4G3G+8X |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 18,24 | 34,24 | 0,53 | -22,35 | 2,33 | 16,34 | 1,28 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 26.06.2025 | 22.05.2025 | 21.08.2025 | 21.11.2025 | 17.04.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +1,44% | +12,90% | +38,32% | +21,62% | -43,75% |
